Please register to participate in our discussions with 2 million other members - it's free and quick! Some forums can only be seen by registered members. After you create your account, you'll be able to customize options and access all our 15,000 new posts/day with fewer ads.
The drug, called bexarotene, has been on the market for about 10 years to treat T-cell lymphoma, often after other treatments have failed. But bexarotene can do a completely different job in the brain, researchers report online February 9 in Science.
Just hours after mice began taking bexarotene, levels of the smaller kind of A-beta in their brains fell, reaching a 25 percent reduction after 24 hours. After 14 days of treatment, plaque levels fell by 75 percent, the team reports.
“Nothing tested comes anywhere close to the speed with which existing amyloid is washed away by this drug,” says neurologist and neuroscientist Samuel Gandy of Mount Sinai Hospital in New York City.
WOW That is great news !!! I hope they start handing it out to people who think they are starting to get this awful illness (me). I see a movie one day, and the next day cannot remember a thing about it except the name. It generally comes back after awhile, but am fearful this may be a omen of things to come...
Yeah it is good news. They just need to try it on more people. I guess since it's a drug that's already been used for cancer they should already know of the effects so they can start using it to treat human alzheimer's sooner.
Please register to post and access all features of our very popular forum. It is free and quick. Over $68,000 in prizes has already been given out to active posters on our forum. Additional giveaways are planned.
Detailed information about all U.S. cities, counties, and zip codes on our site: City-data.com.